Therefore, to determine whether global loss of Elk1 was sufficient to increase Itgb6 expression in vivo and exacerbate fibrotic responses, we employed the bleomycin model of lung fibrosis. This evidence concerns the gene ELK1 and pulmonary fibrosis.